Sign inJoin waitlistJoin the waitlist

FL

Fa Lee

Medical Director, UCI Health Infusion Center · University of California

Credentials: · · ·

History

UCI Health Infusion Center · University of California
Present
UCI Health Infusion Center
Present
University of California · UCI School of Medicine
Present

Hematology and Medical Oncology
1994–1997
Internal Medicine
1991–1994
Saint Louis University School of Medicine
1987–1991

Research

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer
PLoS ONE · 2013 · 176 citations
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
Journal of Clinical Oncology · 2006 · 80 citations
Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores
Journal of the American Academy of Child & Adolescent Psychiatry · 1994 · Last of 4 authors · 57 citations

Farshid Dayyani
4 papers
IR
Ian Rabinowitz
4 papers
Claire Verschraegen
3 papers
Heinz-Josef Lenz
3 papers
May Cho
3 papers
Al Benson
2 papers
Daniel Haller
2 papers
DS
Deepti Singh
2 papers
DJ
Dennie Jones
2 papers
HS
Harriet Smith
2 papers
Jaffer Ajani
2 papers
James Yao
2 papers

Clinical trials

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
Principal investigator · Withdrawn · Phase 2
New Mexico Cancer Research Alliance
2015–2020
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
Principal investigator · Terminated
New Mexico Cancer Research Alliance
2008–2015
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 2
New Mexico Cancer Research Alliance
2008–2015
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
Principal investigator · Terminated
University of New Mexico
2006–2007